APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA study

Keage, H. A.D.; Matthews, F. E.; Yip, A.; Gao, L.; McCracken, C.; McKeith, I. G.; Rubinsztein, D. C.; Brayne, C.

doi:10.1093/ageing/afp210

All Outputs (1)

APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA study (2009)
Journal Article
Keage, H. A., Matthews, F. E., Yip, A., Gao, L., McCracken, C., McKeith, I. G., …Brayne, C. (2009). APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA study. Age and ageing, 39(1), 104-111. https://doi.org/10.1093/ageing/afp210

Background: dementia risk conferred by apolipoprotein-E (APOE) and angiotensin-1-converting enzyme (ACE) polymorphisms have been reported for the MRC Cognitive Function and Ageing Study (CFAS) at 6-year follow-up. We concentrate on incident dementia... Read More about APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA study.